We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| R&q Insurance Holdings Ltd | LSE:RQIH | London | Ordinary Share | BMG7371X1065 | ORD 2P (DI) |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.075 | 0.00 | 00:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | O | 0 | 0.075 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 29/7/2024 | 06:00 | UK RNS | AIM Cancellation - R&Q INSURANCE HOLDINGS LTD |
| 16/7/2024 | 19:23 | ALNC |  TRADING UPDATES: Cirata to raise cash; Cap-XX teams with Schurter |
| 28/6/2024 | 17:07 | UK RNS | R&Q Insurance Holdings Ltd Sale of Accredited to Onex Partners |
| 27/6/2024 | 06:00 | UK RNS | R&Q Insurance Holdings Ltd Appointment of Joint Provisional Liquidators |
| 24/6/2024 | 14:35 | ALNC | R&Q Insurance announces GBP11.3 million sale of UK business |
| 24/6/2024 | 06:00 | UK RNS | R&Q Insurance Holdings Ltd Update |
| 24/6/2024 | 06:00 | UK RNS | R&Q Insurance Holdings Ltd R&Q agrees sale of Inceptum |
| 20/6/2024 | 15:59 | UK RNS | R&Q Insurance Holdings Ltd TR-1: Notification of major holdings |
| 20/6/2024 | 12:12 | UK RNS | R&Q Insurance Holdings Ltd TR-1: Notification of major holdings |
| 19/6/2024 | 16:24 | ALNC | EARNINGS AND TRADING: International Public invests GBP83 million |
R&q Insurance (RQIH) Share Charts1 Year R&q Insurance Chart |
|
1 Month R&q Insurance Chart |
Intraday R&q Insurance Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 26/9/2024 | 06:28 | RANDALL AND QUILTER, Insurance Specialist | 1,542 |
| 03/1/2012 | 13:33 | Randall & Quilter - Portfolio Acquisition | - |
| 20/10/2011 | 07:42 | Randall & Quilter - Acquisition of Principle Insurance | - |
| 09/9/2011 | 07:56 | Randall & Quilter - In Fine Shape | - |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 19/6/2024 06:15 by tomboyb offload assets and nothing left here -RQIH were telling you in previous RNS they would do this - |
Posted at 13/6/2024 16:48 by simon gordon It seems most of the penny share dreamers are on London South East, not ADVFN.Good luck. |
Posted at 13/6/2024 16:19 by simon gordon Has been since the new Non-Execs, who specialise in liquidation/restructBrandyWine has turned into a poison. - 19 April 2024 R&Q Insurance Holdings Ltd (AIM-RQIH) ("R&Q" or the "Group") announces the appointments to the Board of Stephen Welch and Lawrence Hirsh as Non-Executive Directors, effective from 18 April 2024. Stephen Welch has worked for financial sponsors and investors in both executive and non-executive roles. He has extensive experience managing complex corporate issues, including several restructuring situations of regulated financial services and insurance businesses. Stephen is also a Non-Executive Director of Telegraph Media Group Limited, The Spectator (1828) Limited and the Primary Group Limited. Stephen was a partner at McGrathNicol and a Senior Managing Director at FTI Consulting, and is a Chartered Accountant. Lawrence Hirsh has acted as an independent board member and advisor to a number of companies, providing financial and operational services. Lawrence was previously a Managing Director for Alvarez & Marsal, leading its Southeastern US Corporate Restructuring Practice, and a Partner at Arthur Andersen LLP. As both an advisor and during his career, Lawrence has a track-record of helping drive operational improvements and cost reduction programs. |
Posted at 13/6/2024 07:10 by sbb1x #RQIH RNS out - looks like liquidation unfortunately |
Posted at 12/6/2024 10:25 by gkace the 65m payment is worth 17p per share |
Posted at 10/5/2024 16:35 by simon gordon Hi Bagpuss,Brickell (777) made a bid at 175p which was rejected by Slater and Phoenix. Somewhat weird that they are going into a restructuring around the same time as RQIH. Brickell owned c.25% of RQIH at one stage. |
Posted at 23/4/2024 10:18 by royalles Simon - i think more likely it will be sold as a whole and possibly bought out by one of the regional big boys.In terms of returns to shareholders i would guess somewhere in excess of 18p upto 31p a share.Is all due to be resolved during Q2 so is very much game on to buy current cheapies IMO |
Posted at 14/12/2023 09:03 by controlledmadness This deal seems bad. The items that R&Q are committed to from the purchase price seem to be there to make the price sound better.I can almost understand the load of 46 million having to be repaid . The capital contribution to Accredited should come with some value like shares or be made by the buyer. I am not sure what the extra collateral is for but if it is accredited then the buyer should be paying it. The assumed debt 0f 27 million from accredited should not left with accredited. So at best 27+76 million =103 million should be deducted from the purchase price with the buyer just giving the money to Accredited. So the purchase price is actually 362 million. If the collateral is for Accredited then another 40-80 million need to be deducted from the purchase price. |
Posted at 15/11/2023 14:12 by topvest Very interesting developments here. I did well out of this by backing Ken Randall and exiting when he did. Phoenix and Slater thought they new best and have come thoroughly unstuck. I wonder whether Ken Randall may be tempted back? He would need to buy one of the larger holders shares first. It's back to what it was, with the legacy business, at 1/10th of the price! |
Posted at 16/11/2021 13:46 by simon gordon This fund manager has RQIH in his top ten - here's his commentary for November 2021:Howay Investments Tomorrow’s fish and chip paper Volatility has returned to the stock market in recent weeks due to concerns around strained global supply chains and rising inflation. When volatility is on the rise there is a tendency for many commentators to use share price movements as the determinant of truth for any given company. If a company’s share price rises significantly then it must be because they are doing everything right and if a company’s share price falls significantly then that company must be doing everything wrong. This is clearly not right. Humans regularly over-react to good news and bad news and this naturally plays out in a pronounced way in the melting pot of human emotions that is the stock market. A few weeks ago, Jeff Bezos tweeted a picture of the front cover of Barron’s, the prestigious US financial news journal from May 1999. The headline of the article was ‘Amazon.Bomb&r After the article was published, Amazon’s shares declined by around 70% over the next 2 years and it took another 6 years for the share price to recover to the level before the article was published. Over that period, you can imagine how great the journalist must have felt about his big call on Amazon. He must have been the talk of the office at Barron’s with everyone giving him a high five for getting Amazon right. After all, the share price had plummeted so he must be right, right? Wrong! Today, Amazon is one of the largest companies of all time, it has revolutionized two different industries of the global economy (consumer retail and the Cloud) and Amazon’s share price is around 53x higher than at the date the Barron’s article was first published. $10,000 of shares held then would be worth $530,000 today! It’s not unusual for historic headlines to look ridiculous when we look back on them with the benefit of the passage of time. As the old saying goes, today’s headlines are tomorrow’s fish and chip paper. The Amazon article reminded us of one of the UK’s few ecommerce success stories over the last decade, Ocado, the grocery delivery business. Ocado floated on the London stock exchange in 2010 at a price of 180p per share and by the end of December 2011 the shares had fallen by around two thirds. Most financial analysts at the time were highly disparaging about Ocado. Below are quotes from some of the leading analysts at the time (we have withheld their names to spare their blushes!): “Even at the revised valuation, the company is still overvalued and expensive. We would not be surprised to see hedge funds shorting the stock.” “It is astonishing how high a price is being paid for Ocado.” “Like many, we are buyers of its service, but not the shares at these levels. We think the current price simply asks too much of the company in the next 10 years, especially bearing in mind the starting point.” 10 years later Ocado shares had increased more than 10x from the IPO price and 30x from the December 2011 low. Most UK fund managers missed Ocado in the same way that most US fund managers missed Amazon. Despite having an increasing number of online deliveries arriving at their households over the years, many professional investors failed to spot what was happening with ecommerce, which with the benefit of hindsight now seems obvious to all of us. Why did this happen? We believe the main reason is short-termism. In our view, many professional investors spend too much time focusing on the short-term financial performance of businesses and insufficient time thinking about their long-term potential. All of the Ocado quotes above stem from the fact that the analysts were too focused on what Ocado was then (a small and unprofitable business) rather than understanding what it could be in the future. Wayne Gretzky, the famous ice hockey legend once described the reason for his success as “I skate to where the puck is going to be, not where it’s been.” Investing is about identifying companies that are attractively valued relative to their future profits. All investors would agree with this statement, but in our view, most focus on business value relative to existing profits. Therein lies a great opportunity for the long-term patient investor. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
